Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
- 1 December 2014
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 384 (9960) , 2123-2131
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impactVaccine, 2013
- Importance of circulating antibodies in protection against meningococcal diseaseHuman Vaccines & Immunotherapeutics, 2012
- Neisseria meningitidis: Biology, Microbiology, and Epidemiology2011
- Carriage ofNeisseria meningitidisin Europe: a review of studies undertaken in the regionExpert Review of Anti-infective Therapy, 2011
- Meningococcal carriage by age: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programsExpert Review of Vaccines, 2009
- Epidemic meningitis, meningococcaemia, and Neisseria meningitidisThe Lancet, 2007
- Social Behavior and Meningococcal Carriage in British TeenagersEmerging Infectious Diseases, 2006
- Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introductionThe Lancet, 2004
- Impact of meningococcal C conjugate vaccine in the UKJournal of Medical Microbiology, 2002